EAM
Exome Asset Management Portfolio holdings
AUM
$110M
1-Year Est. Return
24.83%
1 Year Est. Return
+24.83%
AUM
$112M
AUM Growth
-$21.3M
(-16%)
Holding
78
Top Buys
| 1 | +$4.73M | |
| 2 | +$3.72M | |
| 3 | +$2.93M | |
| 4 |
Regenxbio
RGNX
|
+$2.9M |
| 5 |
Dyne Therapeutics
DYN
|
+$2.7M |
Top Sells
| 1 | +$4.58M | |
| 2 | +$4.46M | |
| 3 | +$3.81M | |
| 4 |
Bristol-Myers Squibb
BMY
|
+$3.69M |
| 5 |
Boston Scientific
BSX
|
+$3.62M |
Sector Composition
| 1 | Healthcare | 98.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Rhythm Pharmaceuticals
RYTM
$7.12B
| – | – |
0
|
|
||
77
Tarsus Pharmaceuticals
TARS
$2.99B
| – | – |
-28,178
|
|